Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12879-017-2381-1 http://scihub22266oqcxt.onion/10.1186/s12879-017-2381-1 C5395857!5395857!28420334     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       BMC+Infect+Dis 2017 ; 17 (ä): ä Nephropedia Template TP {{tp|p=28420334|t=2017. Mucormycosis in renal transplant recipients: review of 174 reported cases |pdf=|usr=}}{{28420334}} gab.com Text Mucormycosis in renal transplant recipients: review of 174 reported cases JO: BMC Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=28420334 #FOAvip Background: Mucormycosis is a highly lethal fungal infection especially in immunocompromised individuals. Methods: In order to review the epidemiology, diagnosis, and treatment of mucormycosis in renal transplant recipients we searched publications of mucormycosis cases in renal transplant recipients in PUBMED database up to December 2015. Results: A total of 174 cases in renal transplant recipients were included in this review. Most of the cases (76%) were male. Major underlying diseases were diabetes mellitus (43.1%). Rhinocerebral was the most common site of infection (33.3%). Rhizopus species was the most frequent fungus (59.1%) in patients with pathogen identified to species level. The mortality rates of disseminated mucormycosis (76.0%) and graft renal (55.6%) were higher than infection in other sites. The overall survival in patients received surgical debridement combined with amphotericin B/posaconazole (70.2%) was higher than those who received antifungal therapy alone (32.4%), surgery alone (36.4%) or without therapy (0%) (p < 0.001). The overall survivals in patients receiving posaconazole and lipid amphoterincin B were higher than that receiving deoxycholate formulation (92.3% and 73.4% vs 47.4%). Conclusions: Mucormycosis is a severe infection in renal transplant recipients. Surgical debridement combined with antifungals, especially liposomal amphotericin B and posaconazole, can significantly improve patient?s overall survival. Electronic supplementary material: The online version of this article (doi:10.1186/s12879-017-2381-1) contains supplementary material, which is available to authorized users. Twit Text FOAVip Mucormycosis in renal transplant recipients: review of 174 reported cases ????BMC Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=28420334 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28420334 #FOAvip English Wikipedia <ref>{{Cite pmid|28420334}}</ref> Mucormycosis in renal transplant recipients: review of 174 reported cases #MMPMID28420334 Song Y; Qiao J; Giovanni G; Liu G; Yang H; Wu J; Chen J BMC Infect Dis 2017[]; 17 (ä): ä PMID28420334show ga Background: Mucormycosis is a highly lethal fungal infection especially in immunocompromised individuals. Methods: In order to review the epidemiology, diagnosis, and treatment of mucormycosis in renal transplant recipients we searched publications of mucormycosis cases in renal transplant recipients in PUBMED database up to December 2015. Results: A total of 174 cases in renal transplant recipients were included in this review. Most of the cases (76%) were male. Major underlying diseases were diabetes mellitus (43.1%). Rhinocerebral was the most common site of infection (33.3%). Rhizopus species was the most frequent fungus (59.1%) in patients with pathogen identified to species level. The mortality rates of disseminated mucormycosis (76.0%) and graft renal (55.6%) were higher than infection in other sites. The overall survival in patients received surgical debridement combined with amphotericin B/posaconazole (70.2%) was higher than those who received antifungal therapy alone (32.4%), surgery alone (36.4%) or without therapy (0%) (p < 0.001). The overall survivals in patients receiving posaconazole and lipid amphoterincin B were higher than that receiving deoxycholate formulation (92.3% and 73.4% vs 47.4%). Conclusions: Mucormycosis is a severe infection in renal transplant recipients. Surgical debridement combined with antifungals, especially liposomal amphotericin B and posaconazole, can significantly improve patient?s overall survival. Electronic supplementary material: The online version of this article (doi:10.1186/s12879-017-2381-1) contains supplementary material, which is available to authorized users. äMucormycosis in renal transplant recipients: review of 174 reported ca(epmc).pdf DeepDyve Pubget Overpricing